Indication
HIV
Assets addressing this indication.
Total attributable cost
$59.5B
$53,945/patient
Drug spend
$46.2B
$41,834/patient
78% of total cost is drugs
All stages, diagnosed (2024 estimate) · US
Indication
Assets addressing this indication.
Total attributable cost
$59.5B
$53,945/patient
Drug spend
$46.2B
$41,834/patient
78% of total cost is drugs
All stages, diagnosed (2024 estimate) · US
61 of 61 assets